Genital Herpes Market Report 2026

Genital Herpes Market Overview

• Genital Herpes market size has reached to $2.34 billion in 2025 • Expected to grow to $3.15 billion in 2030 at a compound annual growth rate (CAGR) of 6% • Growth Driver: Rising Sexual Health Awareness To Drive Genital Herpes Market Growth • Market Trend: Strategic Partnerships Enhancing Technological Capabilities And Market Reach • North America was the largest region in 2025.

What Is Covered Under Genital Herpes Market?

Genital herpes refers to a sexually transmitted infection (STI) caused primarily by the herpes simplex virus type 2 (HSV-2) or, less commonly, by the herpes simplex virus type 1 (HSV-1). It typically manifests as sores or blisters on the genital area, buttocks, or anal region. Genital herpes is transmitted through sexual contact with an infected person and can be managed with antiviral medications to reduce symptoms and prevent transmission to sexual partners. The main types of genital herpes include diagnosis and treatment. Diagnosis refers to the methods and procedures used to identify the presence of genital herpes in patients, which can include physical examinations, laboratory tests, and patient history reviews to confirm the infection. The routes of administration include oral, injectable, and topical, and the distribution channels include hospital pharmacies, retail pharmacies, and others.

What Is The Genital Herpes Market Growth Forecast?

The genital herpes market size is expected to see strong growth in the next few years. It will grow to $3.15 billion in 2030 at a compound annual growth rate (CAGR) of 6.0%. The growth in the forecast period can be attributed to development of preventive vaccines, expansion of rapid diagnostics, improved patient adherence therapies, digital sexual health services, increased healthcare access. Major trends in the forecast period include increasing use of antiviral suppressive therapy, rising awareness and early diagnosis of stis, growing demand for point-of-care diagnostic tests, expansion of preventive sexual health programs, increased focus on long-term symptom management.

Global Genital Herpes Market Segmentation

1) By Type: Diagnosis, Treatment 2) By Route Of Administration: Oral, Injectable, Topical 3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Other Distribution Channel Subsegments: 1) By Diagnosis: Polymerase Chain Reaction (PCR) Tests, Viral Culture Tests, Blood Antibody Tests (Serology), Antigen Detection Tests, Point-Of-Care Rapid Tests 2) By Treatment: Antiviral Medications, Acyclovir, Valacyclovir, Famciclovir, Topical Treatments, Acyclovir Cream, Docosanol Cream, Preventive Therapies, Suppressive Therapy, Prophylactic Vaccines (Under Development), Pain Management Medications, Analgesics, Topical Anesthetics

What Is The Driver Of The Genital Herpes Market?

The rising focus on sexual health is expected to propel the growth of the genital herpes market going forward. The rising focus on sexual health stems from increasing recognition of its significant role in overall health and quality of life. The use of sexual health services for genital herpes primarily involves diagnosis, treatment, counseling, and ongoing management to support individuals in managing outbreaks, preventing transmission, and addressing emotional and relationship concerns associated with the condition. For instance, in September 2025, according to the Centers for Disease Control and Prevention, a US-based government public health agency, it was reported that in 2024, more than 2.2 million cases of chlamydia, gonorrhea, and syphilis were reported. Therefore, the rising focus on sexual health will drive the growth of the genital herpes industry.

Key Players In The Global Genital Herpes Market

Major companies operating in the genital herpes market are Merck & Co Inc, Abbott Laboratories, GlaxoSmithKline plc, Viatris Inc, Teva Pharmaceuticals Inc, Sandoz Inc, Valeant Pharmaceuticals International Inc, Sun Pharmaceutical Industries Ltd, Dr Reddy’s Laboratories Ltd, Apotex Inc, Zydus Group, Genocea Biosciences Inc, Glenmark Pharmaceuticals Inc, Maruho Co Ltd, Eurocine Vaccines AB, Vical Incorporated, Gilead Sciences Inc, Johnson & Johnson Inc, AstraZeneca plc, Moderna Inc, Assembly Biosciences Inc

Global Genital Herpes Market Trends and Insights

Major companies operating in the genital herpes market are increasingly forming strategic partnerships to expand technological capabilities and strengthen market reach. A strategic partnership involves collaboration between organizations that combine their resources, expertise, and efforts to achieve shared objectives. For example, in December 2024, Changchun Baike Biotechnology, a China-based biotechnology company, and Zhuhai Livanda Biotechnology, a China-based biopharmaceutical company, jointly received approval from China’s National Medical Products Administration to initiate clinical trials for LVRNA101, a multi-component mRNA vaccine for Herpes Simplex Virus Type 2 (HSV-2, genital herpes). The vaccine is designed to generate both humoral and cellular immune responses using advanced mRNA technology.

What Are Latest Mergers And Acquisitions In The Genital Herpes Market?

In October 2023, Gilead Sciences, a US-based biopharmaceutical company specializing in antiviral therapeutics for HIV, hepatitis, and other viral infections, entered into a strategic partnership with Assembly Biosciences for the development of next-generation therapies targeting serious viral diseases, including genital herpes (HSV-2). With this partnership, the companies aim to leverage combined expertise to accelerate the development and commercialization of innovative antiviral therapies, enhancing therapeutic capabilities and expanding market presence in the viral disease segment. Assembly Biosciences is a US-based biopharmaceutical company focused on developing novel therapeutics for viral infectious diseases, including long-acting helicase-primase inhibitors for recurrent genital herpes.

Regional Outlook

North America was the largest region in the genital herpes market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Genital Herpes Market?

The genital herpes market consists of revenues earned by entities by providing services such as diagnostic testing, patient education, counseling, and management of symptoms and outbreaks. The market value includes the value of related goods sold by the service provider or included within the service offering. The genital herpes market also includes sales of antiviral medications, topical treatments, diagnostic test kits, and preventive products like vaccines. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Genital Herpes Market Report 2026?

The genital herpes market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the genital herpes industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.